Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.69, No.1, p.165–173, 2022 |
||
Title: Establishment of PANDA - a new human pancreatic ductal adenocarcinoma cell line with 3D cell culture technology | ||
Author: Romana Zahumenska, Michal Kalman, Juraj Marcinek, Sandra Mersakova, Martin Kertys, Miroslav Pindura, Blazej Palkoci, Roman Kycina, Martin Vojtko, Tomas Chromec, Hugo Maurice Dumortier, Slavomira Novakova, Barbora Mitruskova, Ivan Kapralik, Dusan Loderer, Marian Grendar, Dusan Brany, Juraj Mokry, Michael Bouvet, Mark A Valasek, Jan Janik, Lukas Plank, Ludovit Laca, Erika Halasova, Jan Strnadel | ||
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive type of malignancy with one of the worst prognoses amongst any type of cancer. Surgery is applicable only to the limited number of patients with locally resectable tumors and currently represents the only curative treatment option. Treatment with chemotherapy and radiotherapy can only extend patient survival. Despite advances in conventional therapies, the five-year survival of PDAC remained largely unchanged. New in vitro and in vivo models are therefore urgently needed to investigate this type of cancer. Here, we present the establishment and characterization of a novel pancreatic cancer cell line, isolated from a patient with PDAC. Cell line abbreviated as PANDA (PANncreatic Ductal Adenocarcinoma) was established with an optimized 3D culture protocol published previously by our group. The new cancer cell line "PANDA" represents a novel in vitro approach for PDAC cancer research and new therapy testing. |
||
Keywords: pancreatic ductal adenocarcinoma; cancer cell line; in vitro models; 3D culture | ||
Published online: 24-Nov-2021 | ||
Year: 2022, Volume: 69, Issue: 1 | Page From: 165, Page To: 173 | |
doi:10.4149/neo_2021_210924N1360 |
||
|
download file |
|